Paul Gillette

Suneva Medical has acquired a new product line, including worldwide rights to Refissa (tretinoin 0.05 percent), from Spear Pharmaceuticals.

A person’s eye color may help to predict risk for vitiligo, according to results of a new study.

A new study shows that a hormone that is associated with maintaining bone health may also help to boost antimicrobial peptide (AMP) expression when dietary vitamin D levels are low.

Scientists have taken skin cells from patients with advanced heart failure and used them to create healthy, patient-specific heart muscle cells, according to results of a recent study.

New research suggests aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) may help protect against skin cancer.

Another recent study has shown that the BRAF inhibitor dabrafenib is safe and effective in treating advanced melanoma.

Swiss drugmaker Novartis has signed an agreement to acquire Fougera Pharmaceuticals for more than $1.5 billion in cash.

Data from an ongoing clinical evaluation of a combination of two drugs in patients with advanced melanoma is showing promise as a new way of treating the disease.

A recently published study suggests vigorous exercise may be associated with a lower risk of psoriasis.

A watchdog organization has released a report indicating more than 50 percent of tested sunscreens contain ingredients that have the potential to cause cell damage and skin cancer.

Cosmetic manufacturer L’Oréal?s attempt to trademark products with a similar name to Botox (onabotulinumtoxinA, Allergan), was rejected by the top European Union court.

Langerhans cells (LCs), immune cells found in the skin, can be both helpful and harmful, allowing beneficial microbes to live as well as attacking harmful foreign bodies, depending on the situation, a new study proposes.

New research proposes that zinc oxide, a common ingredient in sunscreens, may not be as effective as previously thought and may actually cause damage to cells.

Many young adults engage in high-risk sun exposure and indoor tanning behaviors even as skin cancer rates among this age group continue to rise, according to recent studies by the Centers for Disease Control and Prevention and the National Cancer Institute.

Vermont residents under age 18 will have to wait until the sun is out to tan. A new law there will ban the use of indoor tanning beds by minors, making it the second state in the country, after California, to place an age restriction on indoor tanning.